February 2024
1. CHOI H, Cho SW, Kim HH, Yi KH, et al
   Shortened telomere length in peripheral blood leukocytes is associated with cumulative radioactive iodine doses in patients with differentiated thyroid carcinoma.
   Cancer. 2024 Feb 20. doi: 10.1002/cncr.35256.
   

   >> Share

   
   January 2024
2. GROSS ND, Seiwert TY
   Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care?
   Cancer. 2024 Jan 18. doi: 10.1002/cncr.35198.
   

   >> Share

   
   
3. NIERENGARTEN MB
   Novel biomarker significantly improves diagnostic accuracy for nasopharyngeal cancer.
   Cancer. 2024;130:172.
   

   >> Share

   
   
4. NIERENGARTEN MB
   Oral health linked to survival in head and neck cancer.
   Cancer. 2024;130:171.
   

   >> Share

   
   December 2023
5. 
   Researchers identify two new subtypes of HPV-associated head and neck cancers.
   Cancer. 2023;129:3842.
   

   >> Share

   
   October 2023
6. CARPENTER DJ, Patel P, Niedzwiecki D, Dillon M, et al
   Long-term risk of carotid stenosis and cerebrovascular disease after radiation therapy for head and neck cancer.
   Cancer. 2023 Oct 28. doi: 10.1002/cncr.35089.
   

   >> Share

   
   
7. PHILIPS R, Alnemri A, Amin D, Patel J, et al
   Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer.
   Cancer. 2023 Oct 3. doi: 10.1002/cncr.35045.
   

   >> Share

   
   September 2023
8. FUNT SA, Knezevic A, Wilson K, Bromberg M, et al
   Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumors.
   Cancer. 2023 Sep 16. doi: 10.1002/cncr.34991.
   

   >> Share

   
   
9. ZHANG L, San Valentin EMD, John TM, Jenq RR, et al
   Influence of oral microbiome on longitudinal patterns of oral mucositis severity in patients with squamous cell carcinoma of the head and neck.
   Cancer. 2023 Sep 8. doi: 10.1002/cncr.35001.
   

   >> Share

   
   July 2023
10. PATEL SA, Gibson MK, Deal A, Sheth S, et al
    A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma.
    Cancer. 2023 Jul 3. doi: 10.1002/cncr.34930.
    

    >> Share

    
    May 2023
11. HARING CT, Kana LA, Dermody SM, Brummel C, et al
    Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.
    Cancer. 2023 May 10. doi: 10.1002/cncr.34823.
    

    >> Share

    
    
12. 
    Erratum to "Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinoma".
    Cancer. 2023 May 2. doi: 10.1002/cncr.34829.
    

    >> Share

    
    
13. RAMKUMAR SP, Simpson MC, Adjei Boakye E, Bukatko AR, et al
    High-risk human papillomavirus 16/18 associated with improved survival in sinonasal squamous cell carcinoma.
    Cancer. 2023;129:1372-1383.
    

    >> Share

    
    April 2023
14. YAN L, Li Y, Li XY, Xiao J, et al
    Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
    Cancer. 2023 Apr 15. doi: 10.1002/cncr.34802.
    

    >> Share

    
    
15. D'SOUZA G, Tewari SR, Troy T, Waterboer T, et al
    Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.
    Cancer. 2023 Apr 9. doi: 10.1002/cncr.34783.
    

    >> Share

    
    February 2023
16. QUAN DL, Grauer JS, Sunkara PR, Cramer JD, et al
    Surgical salvage of human papillomavirus-positive oropharyngeal cancer: Secondary analysis of a randomized controlled trial.
    Cancer. 2023;129:376-384.
    

    >> Share

    
    January 2023
17. VERMA A, Burtness B
    Top advances of the year: Head and neck cancer.
    Cancer. 2023 Jan 24. doi: 10.1002/cncr.34654.
    

    >> Share

    
    
18. LEE JJW, Kunaratnam V, Kim CJH, Pienkowski M, et al
    Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis.
    Cancer. 2023 Jan 18. doi: 10.1002/cncr.34620.
    

    >> Share

    
    November 2022
19. KOYUNCU CF, Nag R, Lu C, Corredor G, et al
    Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Cancer. 2022;128:3831-3842.
    

    >> Share

    
    October 2022
20. 
    Sharp rise in esophageal cancer and Barrett esophagus seen in middle-aged people.
    Cancer. 2022;128:3584-3585.
    

    >> Share

    
    August 2022
21. LIN Y, Bruner DW, Paul S, Miller AH, et al
    A network analysis of self-reported psychoneurological symptoms in patients with head and neck cancer undergoing intensity-modulated radiotherapy.
    Cancer. 2022 Aug 15. doi: 10.1002/cncr.34424.
    

    >> Share

    
    July 2022
22. MAZUL AL, Hartman CM, Mowery YM, Kramer JR, et al
    Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV-negative veterans.
    Cancer. 2022 Jul 22. doi: 10.1002/cncr.34387.
    

    >> Share

    
    
23. HSUEH CY, Lau HC, Huang Q, Gong H, et al
    Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck.
    Cancer. 2022 Jul 5. doi: 10.1002/cncr.34338.
    

    >> Share

    
    June 2022
24. 
    Erratum to "Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study".
    Cancer. 2022 Jun 24. doi: 10.1002/cncr.34358.
    

    >> Share

    
    
25. O'BOYLE CJ, Siravegna G, Varmeh S, Queenan N, et al
    Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    Cancer. 2022;128:2193-2204.
    

    >> Share

    
    May 2022
26. HUANG SH, Jacinto JCK, O'Sullivan B, Su J, et al
    Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.
    Cancer. 2022 May 19. doi: 10.1002/cncr.34266.
    

    >> Share

    
    
27. NELSON TJ, Thompson CA, Zou J, Kumar A, et al
    Validation of NRG Oncology's prognostic nomograms for oropharyngeal cancer in the Veterans Affairs database.
    Cancer. 2022;128:1948-1957.
    

    >> Share

    
    April 2022
28. HUTCHESON KA, Barbon CEA, Alvarez CP, Warneke CL, et al
    Refining measurement of swallowing safety in the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) criteria: Validation of DIGEST version 2.
    Cancer. 2022;128:1458-1466.
    

    >> Share

    
    March 2022
29. PARK S, Oh D, Choi YL, Chi SA, et al
    Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Cancer. 2022 Mar 23. doi: 10.1002/cncr.34176.
    

    >> Share

    
    
30. SOO J, Jin MC, Beadle BM, Holsinger FC, et al
    Circulating tumor DNA in head and neck cancer: Early successes and future promise.
    Cancer. 2022 Mar 17. doi: 10.1002/cncr.34189.
    

    >> Share

    
    February 2022
31. EKANAYAKE WEERAMANGE C, Shu D, Tang KD, Batra J, et al
    Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Cancer. 2022 Feb 17. doi: 10.1002/cncr.34148.
    

    >> Share

    
    
32. OLIVER JR, Persky MJ, Wang B, Duvvuri U, et al
    Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers.
    Cancer. 2022;128:685-696.
    

    >> Share

    
    
33. SCOTT-WITTENBORN N, D'Souza G, Tewari S, Rooper L, et al
    Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time.
    Cancer. 2022 Feb 8. doi: 10.1002/cncr.34124.
    

    >> Share

    
    December 2021
34. LIANG L, Liu Z, Zhu H, Wang H, et al
    Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open-label, randomized controlled trial.
    Cancer. 2021 Dec 15. doi: 10.1002/cncr.34074.
    

    >> Share

    
    
35. WOTMAN MT, Miles BA, Bakst RL, Posner MR, et al
    A proposal for risk-based and strategy-adapted de-escalation in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2021;127:4330-4338.
    

    >> Share

    
    
36. AGGARWAL P, Hutcheson KA, Garden AS, Mott FE, et al
    Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors.
    Cancer. 2021;127:4470-4480.
    

    >> Share

    
    October 2021
37. TREISTER NS, Brennan MT, Sollecito TP, Schmidt BL, et al
    Exposed bone in patients with head and neck cancer treated with radiation therapy: An analysis of the Observational Study of Dental Outcomes in Head and Neck Cancer Patients (OraRad).
    Cancer. 2021 Oct 19. doi: 10.1002/cncr.33948.
    

    >> Share

    
    
38. REN J, Pang W, Hueniken K, Haddad G, et al
    Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.
    Cancer. 2021 Oct 1. doi: 10.1002/cncr.33936.
    

    >> Share

    
    
39. FAKHRY C, Tewari SR, Zhang L, Windon MJ, et al
    RTOG-0129 risk groups are reproducible in a prospective multicenter heterogeneously treated cohort.
    Cancer. 2021;127:3523-3530.
    

    >> Share

    
    September 2021
40. ABDELMEGUID AS, Hanna EY
    Reply to Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses-Is it worthwhile?
    Cancer. 2021;127:3265.
    

    >> Share

    
    
41. PANDA S, Raveendran S, Kumar R, Thakar A, et al
    Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses-Is it worthwhile?
    Cancer. 2021;127:3264.
    

    >> Share

    
    
42. WU J, Xiao F, Zheng Y, Lin Y, et al
    Worldwide trend in human papillomavirus-attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030.
    Cancer. 2021;127:3172-3182.
    

    >> Share

    
    
43. RYAN WR, Xu MJ, Ochoa E, Plonowska-Hirschfeld KA, et al
    Oncologic outcomes of human papillomavirus-associated oropharynx carcinoma treated with surgery alone: A 12-institution study of 344 patients.
    Cancer. 2021;127:3092-3106.
    

    >> Share

    
    August 2021
44. GUO TW, Saiyed F, Yao CMKL, Kiong KL, et al
    Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.
    Cancer. 2021;127:2916-2925.
    

    >> Share

    
    
45. SCHRANK TP, Lenze N, Landess LP, Hoyle A, et al
    Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.
    Cancer. 2021;127:2788-2800.
    

    >> Share

    
    July 2021
46. VAN DIJK LV, Mohamed ASR, Ferrarotto R, McCoy LA, et al
    The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry.
    Cancer. 2021;127:2453-2464.
    

    >> Share

    
    
47. WHITMARSH A, Pring M, Thomas SJ, Waylen A, et al
    Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000.
    Cancer. 2021;127:2442-2452.
    

    >> Share

    
    June 2021
48. SABA NF
    Preoperative chemotherapy for sinonasal squamous cell carcinoma (SNSCC): Time to move closer to a definitive answer.
    Cancer. 2021;127:1734-1735.
    

    >> Share

    
    
49. ABDELMEGUID AS, Teeramatwanich W, Roberts DB, Amit M, et al
    Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses.
    Cancer. 2021;127:1788-1795.
    

    >> Share

    
    May 2021
50. JUNG YS, Seok J, Hong S, Ryu CH, et al
    The emergence of oral cavity cancer and the stabilization of oropharyngeal cancer: Recent contrasting epidemics in the South Korean population.
    Cancer. 2021;127:1638-1647.
    

    >> Share

    
    April 2021
51. DAHLSTROM KR, Song J, Thall PF, Fuller CD, et al
    Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis.
    Cancer. 2021;127:1228-1237.
    

    >> Share

    
    
52. DRAKE VE, Fakhry C, Windon MJ, Stewart CM, et al
    Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
    Cancer. 2021;127:1029-1038.
    

    >> Share

    
    March 2021
53. BALACHANDRA S, Kusin SB, Lee R, Blackwell JM, et al
    Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Cancer. 2021;127:850-864.
    

    >> Share

    
    February 2021
54. HO AS, Luu M, Kim S, Tighiouart M, et al
    Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
    Cancer. 2021 Feb 17. doi: 10.1002/cncr.33414.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share